IW
AZN icon

Imprint Wealth’s AstraZeneca AZN Stock Holding History

Imprint Wealth’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.17K Hold
22
– – 0.02% 186
2026
Q1 		$4.34K Sell
22
-1
-4% -$193 0.02% 179
2025
Q4 		$4.14K Sell
23
-22
-49% -$3.86K 0.02% 211
2025
Q3 		$6.91K Buy
+45
New +$6.81K 0.02% 220

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Imprint Wealth's AZN Position: Q2 2026 in Review

Imprint Wealth held its AstraZeneca (AZN) position steady in Q2 2026 at 22 shares worth $4.17K. The position accounts for 0.02% of the portfolio, ranked #186.

Imprint Wealth first reported a position in AZN in Q3 2025 and has held it in 4 quarters since. The position peaked at $6.91K in Q3 2025. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Imprint Wealth held 22 shares of AstraZeneca worth $4.17K as of Q2 2026.
  • Imprint Wealth left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.02% of Imprint Wealth's portfolio in Q2 2026, its #186 holding.
  • Imprint Wealth first reported a position in AstraZeneca in Q3 2025 and has held it in 4 quarters since.
  • Imprint Wealth's AstraZeneca position peaked at $6.91K in Q3 2025.
  • 1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Imprint Wealth's 13F filing for Q2 2026, filed 14 Aug 2026.